These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 3063494)

  • 1. Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Henwood JM; Monk JP
    Drugs; 1988 Jul; 36(1):32-66. PubMed ID: 3063494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.
    Patel SS; Spencer CM
    Drugs; 1996 Jan; 51(1):137-60. PubMed ID: 8741236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Holmes B; Brogden RN; Richards DM
    Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enoxacin and norfloxacin in patients with cystitis.
    Yamamoto M; Nagai T; Takaba H; Hashimoto J; Miyake K
    Hinyokika Kiyo; 1987 Dec; 33(12):2141-4. PubMed ID: 3482344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():113-8. PubMed ID: 3258862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
    Gottlieb PL
    Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quinolones in urinary tract infections and prostatitis.
    Naber KG
    Rev Infect Dis; 1989; 11 Suppl 5():S1321-37. PubMed ID: 2672257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
    Childs SJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.